N	88
Follow-up time, days, median, min-max	667 (386-884)
Age, years, median, min-max	60 (23-74)
Disease, n, percent AML ALL MDS Myelofibrosis NHL Chronic leukemia Other	34 (39%) 9 (10%) 25 (28%) 8 (9%) 5 (6%) 3 (3%) 4 (5%)
Disease Risk Index Low Intermediate High	7 (8%) 72 (82%) 9 (10%)
Donor, n, percent MRD MUD	23 (26%) 65 (74%)
Donor HLA match, n, percent 10/10 or 9/10 allele match 1 Ag mismatch	81 (92%) 7 (8%)
Donor-recipient sex, n, percent M/M M/F F/F F/M	43 (49%) 20 (23%) 16 (18%) 9 (10%)
Conditioning intensity, n, percent Myeloablative Non-myeloablative	36 (41%) 52 (59%)
Conditioning regimen, n, percent TBI-Flu Flu-Treo TBI-Cy TBI-Etopophos Other	50 (57%) 25 (29%) 10 (11%) 2 (2%) 1 (1%)